pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
DPTX-3186
Gastric Cancer
Dewpoint Therapeutics Inc
Preclinical
DR/DME Program
Diabetic Macular Edema
Ceramedix Holding LLC
DRAX EXAMETAZIME
DRAX EXAMETAZIME (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M EXAMETAZIME FOR LEUKOCYTE LABELING)
no indication
JUBILANT
DRAXIMAGE MAA
DRAXIMAGE MAA (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M ALBUMIN AGGREGATED)
← prev
page 78 of 231
next →
131
Pain
89
Neurology
1
no indication
DRAXIMAGE
DROSPIRENONE AND ETHINYL ESTRADIOL
DROSPIRENONE AND ETHINYL ESTRADIOL
no indication
GLENMARK PHARMS LTD
Phase 2
DS-01
DS-01
Irritable Bowel Syndrome
Seed Health Inc
Phase 1
DS-1103
Human Epidermal Growth Factor Receptor 2 Low Breast Cance…
Integral Molecular Inc
Phase 1
DS-2243
Solid Tumor
Daiichi Sankyo Co Ltd
Phase 2
DS-3939
Solid Tumor
Daiichi Sankyo Co Ltd
Phase 1
DS-5361
Head And Neck Squamous Cell Carcinoma (HNSC)
Daiichi Sankyo Co Ltd
Phase 2
DS-7011
Cutaneous Lupus Erythematosus
Daiichi Sankyo Co Ltd
Phase 1
DS-9051
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Daiichi Sankyo Co Ltd
Phase 2
DSG3-CAART
Pemphigus Vulgaris
$CABA
Cabaletta Bio, Inc.
Phase 1
DSP-0038
Alzheimer's Disease
Sumitomo Pharma America Inc
Phase 2
DSP-107
Colorectal Cancer
KAHR medical Ltd
Phase 1
DSP-2342
Unspecified Psychiatric Disorders
Sumitomo Pharma America Inc
Phase 2
DSP-3077
Retinitis Pigmentosa (Retinitis)
Sumitomo Pharma Co Ltd
Phase 1
DSP-3456
Treatment Resistant Depression
Sumitomo Pharma Co Ltd
Phase 1
DST-2105
Keratoconjunctivitis Sicca (Dry Eye)
DelSiTech Ltd
Preclinical
DT-003
Open-Angle Glaucoma
Diorasis Therapeutics
Phase 2
DT-101
Major Depressive Disorder
Draig Therapeutics Ltd
Phase 2
DT-168
Fuchs Endothelial Corneal Dystrophy (FECD)
$DSGN
Design Therapeutics, Inc.
Preclinical
DTI-117
Urinary Retention
Dignify Therapeutics LLC
Preclinical
DTI-301
Constipation
Dignify Therapeutics LLC
Preclinical
DUET-101
Bladder Cancer
Duet Therapeutics Inc
DULOXETINE
DULOXETINE
no indication
INVENTIA
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
no indication
AUROBINDO PHARMA
Phase 1
DVX-201
Myelodysplastic Syndrome (Preleukemia)
$COEP
Coeptis Therapeutics Holdings, Inc.
Phase 2
DX-126262
Gastric Cancer
Hangzhou DAC Biotech Co Ltd
Phase 1
DXDRGB-05
Coronavirus Disease 2019 (COVID-19)
Dx&Vx
